InvestSMART

AVITA Medical, Inc. (ASX:AVH)

ALERT: Price-sensitive ASX Announcement for AVH
Current share price for AVH : $2.700 1.61 (147.71%)+
Announcement
Release
13 Feb 2026 9:43AM
Price at Release
$1.090
Full Release
download
Summary
AVITA Medical, Inc., reported a net loss of $11.6 million for Q4 2025, with total revenue of $17.6 million, a 4% decrease year-over-year, impacted by reimbursement challenges. The company announced a new $60 million credit facility with Perceptive Advisors LLC, aimed at strengthening its capital structure and supporting growth. For the full year 2025, AVITA's revenue rose by 11% to $71.6 million, with a gross profit margin of 82.1%. The company focused on cash efficiency and operating cost reductions, anticipating the normalization of clinician use of RECELL, aided by expanded Medicare reimbursement coverage.
Key Points
  • AVITA Medical reported a net loss of $11.6 million for the fourth quarter of 2025.
  • Total revenue for the quarter was $17.6 million, a decrease of 4% compared to the same period in 2024.
  • The company secured a new credit facility with Perceptive Advisors LLC for up to $60 million.
  • AVITA Medical's full-year 2025 revenue increased by 11% to $71.6 million.
  • The gross profit margin for the year was 82.1%.
  • AVITA Medical focused on reducing operating expenses and improving cash efficiency.
  • The RECELL product continues to gain Medicare reimbursement coverage.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.